Note: After the Food and Drug Administration ... If you drink alcohol, talk with your doctor before you start Skyrizi treatment. They can advise you on how much alcohol may be safe for you ...

Crohn's the third indication for Skyrizi after psoriasis and psoriatic arthritis, and a key step in AbbVie's aim to grow the drug – already one of its top sellers with sales of almost $3 billion ...

rising to 26.2% after a year. Skyrizi – partnered with Boehringer Ingelheim – is already enjoying rapid growth from its approved uses in psoriasis, psoriatic arthritis and Crohn’s disease ...

AbbVie (NYSE:ABBV) is scheduled to announce Q1 earnings results on Friday, April 26th, before market open ... the portfolio based on the strength of Skyrizi and Rinvoq’s launches in IBD ...

AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for immunology powerhouses Skyrizi and Rinvoq by $4 billion. The company now projects more than ...